Sulfacytine
![]() | |
Clinical data | |
---|---|
Routes of administration | Oral |
Identifiers | |
| |
Synonyms | 1-ethyl N4-sulfanilylcytosin, 1-ethyl-N-sulfanilylcytosine, N-sulfanilyl-l-ethylcytosine, Sulfacitina [inn-spanish], Sulfacitinum [inn-latin] |
CAS Number | 17784-12-2 |
PubChem (CID) | 5322 |
DrugBank | DB01298 |
ChemSpider | 5131 |
UNII | T795873AJP |
ChEMBL | CHEMBL1201056 |
Chemical and physical data | |
Formula | C12H14N4O3S |
Molar mass | 294.33 g·mol−1 |
3D model (Jmol) | Interactive image |
| |
|
Sulfacytine is a short-acting sulfonamide antibiotic, taken orally for treatment against bacterial infections. Sulfonamides, as a group of antibiotics, work by inhibiting the bacterial synthesis of folate.[1] In 2006 the drug was discontinued[2][3]
References
- ↑ DrugBank DB01298
- ↑ Federal Register Section: Food and Drug Administration [Docket No. 2006N–0222] Merck & Co., Inc., et al.; Withdrawal of Approval of 65 New Drug Applications and 52 Abbreviated New Drug Applications] Vol. 71, No. 116 / Friday, June 16, 2006. p34941
- ↑ FDA Orange book. Sulfacytine Page accessed May 12, 2015
This article is issued from Wikipedia - version of the 2/26/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.